PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1058672

Extensive drug surveillance--a pilot study.

D C Gerke·E G Easterbrook·D B Frewin·T I Lee
View original source ↗Export metadata ↓

Abstract

The aim of this Extensive Drug Surveillance programme was to develop a system of drug monitoring suitable for detecting adverse drug reactions in hospitalised patients. The monitored field was a general medical ward in the Royal Adelaide Hospital and monitoring was carried out for a period of one month (September 1974). A total of 85 patients (45 males and 40 females) were monitored and in 14 of them adverse reactions were noted. The overall incidence of such reactions was 16.5%. A greater intake of drugs was a significant finding in patients who experienced adverse reactions. Coupled with this was the observation that patients who stayed longer in hospital had a greater number of drugs administered to them. A third finding was the higher incidence of reactions in female patients.

Explore related subjects

Drug PrescriptionsDrug Therapy, CombinationDrug-Related Side Effects and Adverse ReactionsFemaleHumansLength of StayMaleMedication Systems, HospitalPilot ProjectsSex FactorsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D C Gerke, E G Easterbrook, D B Frewin, T I Lee. 1975. Extensive drug surveillance--a pilot study.. https://doi.org/10.1111/j.1445-5994.1975.tb03268.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Clicking for pills.

Explore the source record for details and available documents.

Drug Prescriptions↗
PubMed2007

Safe prescribing.

Explore the source record for details and available documents.

Drug Prescriptions↗
PubMed2007

Provision of pain management by a pharmacist with prescribing authority.

PURPOSE: The clinical and financial outcomes of a pain clinic managed by a pharmacist with prescribing authority are described. SUMMARY: Pharmacist clinicians in a for-profit, integrated health system recently received permission to bill for their services in certain ambulatory clinics. A pharmacist clinician, who had an individual Drug Enforcement Administration number and whose services are billable under New Mexico law, was chosen to assume the medication management responsibilities in a clinic where 90% of the patient population is treated for chronic non-cancer-related pain. No additional personnel were needed, and no additional space was required, eliminating overhead for the space and utilities needed for operating a new clinic. With the ability to bill for the pharmacist clinician's services, a new model for justification of clinical pharmacy services was developed for the ambulatory care clinics. The revenue generated was tracked by a medical billing system, and clinical outcomes were tracked using the clinic's database for patients' individual visual analogue scale (VAS) pain scores. Between June 2004 and June 2005, an average of 18 patients were seen by the pharmacist clinician each day. The clinic generated 107,550 dollars of actual revenue and saved the health plan over 450,000 dollars. There was a consistent decrease in mean VAS pain scores with continued visits. CONCLUSION: Patients with chronic non-cancer-related pain were managed effectively by a pharmacist with prescribing authority and refill authorization in a pain management clinic. The favorable clinical outcomes, revenue generated, and cost savings achieved justified the pharmacist clinician's services in this health system.

Drug Prescriptions↗